Guardion Health Sciences, Inc.

Equities

GHSI

US40145Q5009

Pharmaceuticals

Market Closed - Nasdaq 16:30:00 2024-06-18 EDT 5-day change 1st Jan Change
9.97 USD -0.60% Intraday chart for Guardion Health Sciences, Inc. -1.00% +86.70%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Doctor's Best, Inc. completed the acquisition of Activ Nutritional, LLC. from Guardion Health Sciences, Inc.. CI
Guardion Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
North American Morning Briefing : Hopes of March -2- DJ
Maxim Downgrades Guardion Health Sciences to Hold From Buy MT
Top Midday Gainers MT
Alphabet Earnings, Upcoming Fed Rate Decision Drive Mixed Premarket Action for US Equity Futures MT
Top Premarket Gainers MT
Doctor's Best, Inc. agreed to acquire Activ Nutritional, LLC. from Guardion Health Sciences, Inc. for $17.2 million. CI
Guardion Health Sciences Continues its Strategic Review Process CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Guardion Health Sciences, Inc. Announces Executive Changes CI
US Stock Futures Trend Higher Ahead of Consumer Sentiment Report MT
Top Premarket Decliners MT
Guardion Health Sciences, Inc. Announces Executive Changes CI
Guardion Health Sciences, Inc. Announces CEO Changes CI
Guardion Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Guardion Health Sciences Hires Alantra, LLC as Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value CI
Guardion Health Sciences Regains Compliance With Nasdaq Listing Rules MT
Insider Buy: Guardion Health Sciences MT
Guardion Health Sciences, Inc. announced that it expects to receive $4.75 million in funding CI
Guardion Health Sciences Engages Financial Advisor to Conduct a Strategic Review Process CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Chart Guardion Health Sciences, Inc.
More charts
Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. It sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.
More about the company
  1. Stock Market
  2. Equities
  3. GHSI Stock
  4. News Guardion Health Sciences, Inc.
  5. Guardion Health Sciences Regains Compliance With Nasdaq Listing Rules